Immunomatics Selected to Pitch Live at Superpowers for Good Event on SuperCrowdTV
Transplant survivor-founded healthtech company will present its AI-powered approach to transplant donor risk assessment during the September 30 live pitch event.
SAN MARCOS, CA (September 25, 2026)
Immunomatics, Inc., a health technology company developing artificial intelligence-based tools to improve transplant donor risk assessment, announced today that Founder and CEO Lidio Meireles, PhD, has been selected as an impact founder to pitch the company live at the Superpowers for Good Live Pitch event on Wednesday, September 30.
The event will be broadcast live on SuperCrowdTV and the e360TV Network, giving viewers an opportunity to hear Immunomatics’ story, learn about its technology and mission, and vote during the live competition.
“As a transplant survivor, I experienced firsthand the uncertainty surrounding donor selection,” said Meireles. “That experience ultimately led me to found Immunomatics. Our goal is to give transplant physicians better tools to understand the risks associated with different donor-patient combinations and, ultimately, help make transplants safer.”
During the Superpowers for Good event, Meireles will present Immunomatics before a panel of three judges. Viewers will also be able to participate by voting for their preferred company using their phones.
Following the live broadcast, Immunomatics will participate in a private Zoom session for investors, providing attendees with an opportunity to ask questions directly and learn more about the company and its current equity crowdfunding campaign.
Event details
- Date: Wednesday, September 30, 2026
- Live Pitch: 5:00 PM PT / 8:00 PM ET
- Watch: SuperCrowd.TV via web browser, Roku, or Amazon Fire TV, or through the e360TV Network
- Audience Voting: Live voting available by phone
- Private Investor Q&A: 7:00 PM PT / 10:00 PM ET via Zoom
Registration is free. Attendees may register as Viewers to watch the live pitch or as Investors to watch the broadcast and participate in the private investor Q&A session afterward.
Registration information is available at:
https://thesupercrowd.com/tickets/live-pitch-2026-q3